Big Think

Welcome to Big Think.  |  Register or Log in

  • Home
  • Special Series
  • Topics
  • Experts
  • Blogs
  • Ideafeed
  • Good Word

Experts

Linda Avey Follow

Co-Founder, 23andMe

  • Fnmwilews6fz8p0n5hntoxomdio7jn0m

    Linda Avey on the Peripheral Benefits of the Personal Genomics Industry

    Linda Avey

    The 23andMe co-founder says personal genetic testing will spur new opportunities. Read More

    March 2, 2009   |  In Science & Tech

  • Nwyi7kfh3tmm2rcn5hmzoxomdio6czgg

    Linda Avey on the Risks of Genetic Testing

    Linda Avey

    The 23andMe co-founder says there are risks in any business. Read More

    March 2, 2009   |  In Science & Tech

  • Pyoq_dopikfzsfvn5hmzoxomdio6czgg

    Linda Avey on How to Promote Innovation

    Linda Avey

    The 23andMe co-founder talks about making innovation personal. Read More

    March 2, 2009   |  In Science & Tech

  • B_yyxaqvzomcar4x5hmzoxomdio6czgg

    Linda Avey on the Importance of Genetic Testing

    Linda Avey

    The 23andMe co-founder makes a case for testing your genes. Read More

    March 2, 2009   |  In Science & Tech

  • Twrcackywklueq5h5hmzoxomdio6czgg

    Linda Avey on New Paradigms With Personal Genomics

    Linda Avey

    The 23andMe co-founder on ways to apply your personal genetic data. Read More

    March 2, 2009   |  In Science & Tech

  • 7_xt5jibds5gtfjx5hmzoxomdio6czgg

    Linda Avey on the Collective Genetic Research

    Linda Avey

    The 23andMe co-founder on the benefits of aggregating genetic data. Read More

    March 2, 2009   |  In Science & Tech

  • 5q29rfignnms6-wh5hmzoxomdio6czgg

    Linda Avey Explains 23andMe

    Linda Avey

    The 23andMe co-founder provides some corporate background. Read More

    March 2, 2009   |  In Science & Tech

User_regs_fc853e519 Linda Avey has over 20 years of sales and business development experience in the biopharmaceutical industry in San Francisco, Boston, San Diego, and Washington, D.C. Prior to starting 23andMe, she developed translational research collaborations with academic and pharmaceutical partners for Affymetrix and Perlegen Sciences.Linda also spent time at Spotfire helping scientists understand the power of data visualization and at Applied Biosystems during the early days of the human genome project. The advent of high density genome-wide scanning technologies brought huge potential for significant discoveries. However, the lack of sufficient funding to enable adequate studies prompted Linda to think of a new research model. These ideas led to the formation of 23andMe. Her primary interest is the acceleration of personalized medicine, using genetic profiles to target the right drug to the right person at the correct dose. Linda graduated from Augustana College with a B.A. in biology.

Connect

  • My Website
  • My LeWeb 2008 Interview
  • My Spittoon Posts

Editors' Choice

  • G7wv4oh8zfuiy_e35imzoxomdio0rcfn

    Oliver Sacks on Humans and Myth-making

    Oliver Sacks

  • X5fkhhtchq6hcbhh5hnjoxomdio8hmyi

    When Did You Become Conscious of Race?

    Anna Deavere Smith

People's Choice

  • Thinkorganism

    Thinking Yourself to Orgasm

    Barry Komisaruk

  • Qj20n55c4_1lxkzh5hyjoxomdio92oii

    Five Ways to Become Happier Today

    Tal Ben-Shahar

  • Iprb884q6w6xe2dh5hnzoxomdiozyg5h

    America's New Engine of Growth

    George Soros

  • U_tnbwxjuvzy_lbh5hnjoxomdio8hmyi

    Advice to Aspiring Novelists: Don’t Shoot Yourself

    John Irving

  • S3dfnlztjhaofntx5hczoxomdio1enkt

    Big Think Interview With Rick Perlstein

    Rick Perlstein

Sign Up for our Mailing List

Connect

  • Facebook
  • Twitter
  • About Us
  • Contact Us
  • RSS
  • Privacy
  • Terms of Use

Original content is for Non-commercial use under Creative Commons. Except where otherwise noted.
Some Rights Reserved. Attribution-Noncommercial-Share Alike 3.0 United States License.